Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Chad A. Mirkin to Deliver Pittcon 2011 Plenary Lecture

Abstract:
Most Cited Chemist in the World (Thomson Reuters)

Chad A. Mirkin to Deliver Pittcon 2011 Plenary Lecture

Pittsburgh, PA | Posted on August 23rd, 2010

The Pittcon Program Committee is pleased to announce that Dr. Chad A. Mirkin, Professor of Chemistry, Northwestern University, Evanston, Illinois, will deliver the Pittcon 2011 Plenary Lecture, "Polyvalent DNA Architectures: New Modalities For Intracellular Gene Regulation and Detection" on Sunday, March 13, 2011, at 4:30 p.m., in the Sidney Marcus Auditorium, Georgia World Congress Center, Atlanta, Georgia.

Dr. Chad A. Mirkin is the Director of the International Institute for Nanotechnology, the George B. Rathmann Professor of Chemistry, Professor of Chemical and Biological Engineering, Professor of Biomedical Engineering, Professor of Materials Science & Engineering, and Professor of Medicine."

Dr. Mirkin summarizes, "Over the past decade, we have developed methods for modifying nanoparticles with oligonucleotides and explored how they can be used as designer constructs for preparing highly ordered, highly functional materials. Over the course of these studies, we have discovered many unusual fundamental properties that make these materials particularly useful in biodiagnostics and intracellular gene regulation."

This lecture will focus on the use of these modified nanoparticles in the highly selective and sensitive detection of nucleic acids and proteins. It will also introduce the concept of the "antisense" particle and other similarly functionalized particles. Such particles exhibit a range of unique properties that make them very well-suited for gene regulation. They can also be tailored to control the binding strength to complementary target sequences offering a means to control the degree of protein expression.

See complete abstract here: www.pittcon.org/technical/pdfs/2011/Mirkin_Abstract.pdf

Mirkin is a chemist and a world renowned nanoscience expert, who is known for his development of nanoparticle-based biodetection schemes, the invention of Dip-Pen Nanolithography, and contributions to supramolecular chemistry. He is the author of over 410 manuscripts and over 370 patents and applications, and the founder of three companies, Nanosphere, NanoInk, and AuraSense which are commercializing nanotechnology applications in the life science and semiconductor industries. At present, he is listed as the most cited chemist in the world (Thomson Reuters), and the top most cited nanomedicine researcher in the world (Nanomedicine Registry).

Dr. Mirkin has been recognized for his accomplishments with over 60 national and international awards.

The Plenary Lecture will be part of the Opening Session for Pittcon 2011 which will be held in Atlanta, Georgia, from March 13-18, 2011, Georgia World Congress Center. The Plenary Lecture is followed immediately by a complimentary mixer and poster session. Visit www.pittcon.org/ to get more information on Pittcon 2011.

####

For more information, please click here

Contacts:
Contact:

Melinda Stephens



Marian Nardozzi
800-825-3221

Copyright © Pittcon 2011

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Events/Classes

A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024

Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

June Conference in Grenoble, France, to Explore Pathways to 6G Applications, Including ‘Internet of Senses’, Sustainability, Extended Reality & Digital Twin of Physical World: Organized by CEA-Leti, the Joint EuCNC and 6G Summit Sees Telecom Sector as an ‘Enabler for a Sustainabl June 1st, 2022

Nanobiotechnology

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project